ad image

Baxter International

1 / 1
Using a Risk-Based Approach to Manufacturing in a Multi-Product Facility
Multi-Product Facility Manufacturing

Using a Risk-Based Approach to Manufacturing in a Multi-Product Facility

Peter Boeddeker

Baxter BioPharma Solutions

PAP-Q2-18-CL-009May 29, 2018
Baxter
FDA Clearance

Baxter Announces U.S. FDA Clearance of New Spectrum IQ Infusion System

Baxter

PR-M05-18-NI-059May 16, 2018
Baxter
Collaboration

Baxter and the International Society of Nephrology Announce a Collaboration to Address Growing Prevalence of Kidney Disease

Baxter

PR-M05-18-NI-025May 07, 2018
Baxter Expands Generic Injectables Portfolio with Claris Injectables Acquisition
Expansion

Baxter Expands Generic Injectables Portfolio with Claris Injectables Acquisition

Nice Insight

PAO-M09-17-NI-018Sep 15, 2017
Mayo Clinic and Baxter Launch Patient Centric Kidney Disease Initiative

Mayo Clinic and Baxter Launch Patient Centric Kidney Disease Initiative

Guy Tiene

Nice Insight

PAO-M06-17-NI-004-5421Jun 08, 2017
1 / 1